HIGHLIGHTS
- who: Xujun Ruan et al. from the University, Nanjing, China, Department of Analysis, College of Pharmacy, China University have published the paper: Evaluation of Untargeted Metabolomic Strategy for the Discovery of Biomarker of Breast Cancer, in the Journal: (JOURNAL)
- what: That differential metabolites identified in this study had overlap but not identical with previous studies, which could be attributed to the difference in sample types (tissue, serum or cultured cells).
- how: Aiming at the discovery of biomarker the authors proposed a simplified data processing procedure with improved analysis efficiency. That it was possible . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.